Vivreon Biosciences

Problem -

Inflammation continues to be a significant driver of disease progression in many different indications. And although there are number of therapeutic interventions for curbing inflammation, there are still large patient populations who are inadequate or non-responders to existing therapies.

​

Solution -

We are committed to developing new chemical entities against novel biological targets to reach the large numbers of patients who are refractory to existing anti-inflammatory therapies.